[go: up one dir, main page]

CY1109803T1 - Φαρμακευτικες συνθεσεις που βασιζονται σε ανταγωνιστες νκ2 για παιδιατρικη χρηση - Google Patents

Φαρμακευτικες συνθεσεις που βασιζονται σε ανταγωνιστες νκ2 για παιδιατρικη χρηση

Info

Publication number
CY1109803T1
CY1109803T1 CY20091100493T CY091100493T CY1109803T1 CY 1109803 T1 CY1109803 T1 CY 1109803T1 CY 20091100493 T CY20091100493 T CY 20091100493T CY 091100493 T CY091100493 T CY 091100493T CY 1109803 T1 CY1109803 T1 CY 1109803T1
Authority
CY
Cyprus
Prior art keywords
components
composites based
pediatric use
pharmaceutical composites
pharmaceutical
Prior art date
Application number
CY20091100493T
Other languages
English (en)
Inventor
Alberto Aleotti
Maria Altamura
Carlo Alberto Maggi
Original Assignee
Laboratori Guidotti S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratori Guidotti S.P.A. filed Critical Laboratori Guidotti S.P.A.
Publication of CY1109803T1 publication Critical patent/CY1109803T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Περιγράφονται φαρμακευτικές συνθέσεις που περιέχουν ανταγωνιστές ΝΚ2, χρήσιμες στη θεραπευτική αντιμετώπιση των βρεφικών κολικών.
CY20091100493T 2004-10-27 2009-05-07 Φαρμακευτικες συνθεσεις που βασιζονται σε ανταγωνιστες νκ2 για παιδιατρικη χρηση CY1109803T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000221A ITFI20040221A1 (it) 2004-10-27 2004-10-27 Composizioni farmaceutiche a base di nk2 antagonisti per uso pediatrico
EP05810894A EP1809267B1 (en) 2004-10-27 2005-10-26 Pharmaceutical compositions based on nk2 antagonists for pediatric use

Publications (1)

Publication Number Publication Date
CY1109803T1 true CY1109803T1 (el) 2014-09-10

Family

ID=35613882

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100493T CY1109803T1 (el) 2004-10-27 2009-05-07 Φαρμακευτικες συνθεσεις που βασιζονται σε ανταγωνιστες νκ2 για παιδιατρικη χρηση

Country Status (26)

Country Link
US (2) US7727955B2 (el)
EP (1) EP1809267B1 (el)
JP (1) JP2008517977A (el)
CN (1) CN101052386A (el)
AR (1) AR051595A1 (el)
AT (1) ATE422881T1 (el)
AU (1) AU2005298629B2 (el)
CA (1) CA2584481C (el)
CY (1) CY1109803T1 (el)
DE (1) DE602005012857D1 (el)
DK (1) DK1809267T3 (el)
EA (1) EA012264B1 (el)
ES (1) ES2325413T3 (el)
HK (1) HK1109335A1 (el)
HR (1) HRP20090225T1 (el)
IT (1) ITFI20040221A1 (el)
MX (1) MX2007004461A (el)
NO (1) NO338586B1 (el)
NZ (1) NZ555380A (el)
PL (1) PL1809267T3 (el)
PT (1) PT1809267E (el)
RS (1) RS50780B (el)
SI (1) SI1809267T1 (el)
UA (1) UA91988C2 (el)
WO (1) WO2006045820A1 (el)
ZA (1) ZA200703909B (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0614970D0 (en) * 2006-07-27 2006-09-06 R & D Sosei Ltd Compounds For Use In Therapy
IT1394304B1 (it) * 2009-05-21 2012-06-06 Malesci Sas Processo per la preparazione di ibodutant (men15596) e relativi intermedi
ITRM20120331A1 (it) * 2012-07-12 2014-01-13 Guidotti & C Spa Labor Composizioni pediatriche orali liquide contenenti nepadutant.
US20160051596A1 (en) * 2014-08-21 2016-02-25 Food Industry Research And Development Institute Novel acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase
US9867857B2 (en) 2014-08-21 2018-01-16 Food Industry Research And Development Institute Acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0219318A (ja) * 1988-06-30 1990-01-23 Carl R Thornfeldt 疝痛及び生歯に対する治療
IT1277835B1 (it) 1995-03-13 1997-11-12 Menarini Farma Ind Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche
IT1307809B1 (it) * 1999-10-21 2001-11-19 Menarini Ricerche Spa Composti monociclici basici ad azione nk-2 antagonista, processi difabbricazione e formulazioni che li contengono.
MY130373A (en) * 2001-10-29 2007-06-29 Malesci Sas Linear basic compounds having nk-2 antagonist activity and formulations thereof
GB0224788D0 (en) 2002-10-24 2002-12-04 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
SI1809267T1 (sl) 2009-06-30
NO20072720L (no) 2007-07-09
AU2005298629B2 (en) 2011-02-17
US20080090795A1 (en) 2008-04-17
US20100234284A1 (en) 2010-09-16
AU2005298629A1 (en) 2006-05-04
AR051595A1 (es) 2007-01-24
PL1809267T3 (pl) 2009-07-31
WO2006045820A1 (en) 2006-05-04
ES2325413T3 (es) 2009-09-03
MX2007004461A (es) 2007-07-11
CA2584481C (en) 2014-07-15
EP1809267A1 (en) 2007-07-25
RS50780B (sr) 2010-08-31
EA012264B1 (ru) 2009-08-28
ITFI20040221A1 (it) 2005-01-27
NZ555380A (en) 2008-12-24
JP2008517977A (ja) 2008-05-29
NO338586B1 (no) 2016-09-12
HK1109335A1 (en) 2008-06-06
UA91988C2 (ru) 2010-09-27
HRP20090225T1 (en) 2009-05-31
CA2584481A1 (en) 2006-05-04
EA200700949A1 (ru) 2007-10-26
DE602005012857D1 (de) 2009-04-02
ATE422881T1 (de) 2009-03-15
DK1809267T3 (da) 2009-05-18
EP1809267B1 (en) 2009-02-18
US7727955B2 (en) 2010-06-01
CN101052386A (zh) 2007-10-10
PT1809267E (pt) 2009-05-28
ZA200703909B (en) 2008-09-25

Similar Documents

Publication Publication Date Title
CY1118007T1 (el) Μεθοδοι για την χορηγηση υπογλυκαιμικων μεσων
CY1110965T1 (el) Επιπροσθετες ετεροπολυκυκλικες ενωσεις και η χρηση τους ως ανταγωνιστες μεταβολοτροπικου υποδοχεα γλουταμικου
SE0301700D0 (sv) Novel compounds
EA201100062A1 (ru) Соединения и способы модулирования рецепторов, связанных с белком g
MX2010006206A (es) Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
CY1108843T1 (el) 3,11β cis διϋδροτετραβεναζινη για την θεραπεια της σχιζοφρενιας και αλλων ψυχωσεων
EA201100158A1 (ru) Антагонисты активина-actriia и их применение для стимулирования роста кости
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
EA201170227A1 (ru) Имидазолкарбоксамиды
EA200501430A1 (ru) Лиганды каннабиноидных рецепторов и их применение
MA32568B1 (fr) Formulations pharmaceutiques contenant des ligands de recepteur de dopamine
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
DE602005009748D1 (de) 3-phenyl-pyrazol-derivate als modulatoren des zur behandlung damit zusammenhängender störungen nützlichen 5-ht-2a-serotonin-rezeptors
EA200970302A1 (ru) Тиофенпиразолопиримидиновые соединения
DK1654253T3 (da) Substituerede 3-pyrrolidinindolderivater
ATE459620T1 (de) Benzimidazolthiophenverbindungen als plk- modulatoren
CY1109803T1 (el) Φαρμακευτικες συνθεσεις που βασιζονται σε ανταγωνιστες νκ2 για παιδιατρικη χρηση
IN2012DN03844A (el)
MY157425A (en) Substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
EA200600404A1 (ru) Пероральные препаративные формы кладрибина
NO20064793L (no) Anvendelse av N-(2-arylpropionyl) sulfonamider for behandling av ryggmargskade.
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
CY1116166T1 (el) Νεα μεθοδος για την αντιμετωπιση λοιμωξεων απο η.pylori
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
UY29756A1 (es) Derivados de 5-piridazinil-1-azabiciclo(3.2.1) octano, su preparación y su aplicación en terapéutica.